Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma - Kamel Laribi; Alix Baugier de Materre; Yamina Touileb; Charles Boursot; Jeremy Sandrini; Doriane Cavalieri; Cédric Pastoret; Laurence de Leval; Olivier Tournilhac (HemaSphere, 2022)